This is similar to the findings of Yu et al., who concluded that L1CAM was a predictor of PFS in non-small-cell lung cancer patients and that positive expression of L1CAM suggested a poorer survival outcome [68]. Here, L1CAM is linked to non-small cell lung carcinoma.